Security key
641288105
NeuroPace Inc - Common Stock, $0.01 par value (NPCE)
CUSIP: 641288105
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 11,190,051
- Total 13F value
- $177,393,000
- Share change
- +200,439
- SEC-reported price per share
- $15.85
- Number of holders
- 39
- Value change
- +$509,015
- Number of buys
- 17
- Number of sells
- 19
- Shares outstanding
- 34,317,804
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
39
Top holders
10
NPCE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
NeuroPace Inc SEC filings
NeuroPace Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 641288105
Recent filing periods:
Ownership snapshot
Top reported holders of NPCE - NeuroPace Inc - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F
Highest disclosed value: $95,452,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC has the largest disclosed position value at $95.45M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
ORBIMED ADVISORS LLC
$95.45M
Soleus Capital Management, L.P.
$32.94M
FMR LLC
$25.22M
Bellevue Group AG
$12.08M
PICTET ASSET MANAGEMENT LTD
$11.56M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$95,452,000
4,012,281 shares
|
— | 30 Jun 2021 |
| Soleus Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$32,935,000
1,384,387 shares
|
— | 30 Jun 2021 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$25,219,000
1,060,059 shares
|
— | 30 Jun 2021 |
| Bellevue Group AG |
13F
Company
|
—
denominator unverified
|
$12,084,000
507,930 shares
|
— | 30 Jun 2021 |
| PICTET ASSET MANAGEMENT LTD |
13F
Company
|
—
denominator unverified
|
$11,561,000
485,964 shares
|
— | 30 Jun 2021 |
| SECTORAL ASSET MANAGEMENT INC |
13F
Company
|
—
denominator unverified
|
$11,228,000
471,966 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
11,190,051
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
44
Q3 2021 holders
39
Holder diff
-5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend